Barron's

FirstCash Holdings Inc.

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...
Ars Technica

Google’s TurboQuant AI-compression algorithm can reduce LLM memory usage by 6x

Even if you don’t know much about the inner workings of generative AI models, you probably know they need a lot of memory. Hence, it is currently almost impossible to buy a measly stick of RAM without ...
Seeking Alpha

FirstCash: Strong Business Prospects, But Current Valuation Limits Margin Of Safety

FirstCash Holdings trades at 27x P/E and 3.7x P/B, offering a limited margin of safety at current valuations. FCFS benefits from gold price tailwinds and has the possibility to continue performing ...
FierceBiotech

Disc lays off 20% of employees to steady ship after FDA rejection of rare disease drug

Disc Medicine is laying off a fifth of its workforce as the biotech reels from the FDA’s rejection of its rare blood disease candidate. Last month, the agency knocked back an approval application for ...
The Motley Fool

Disc Medicine Lands New $20 Million Investment as FDA Sets Up Potential Q4 Catalyst

Disc Medicine develops novel therapeutics targeting hematologic diseases, with a pipeline focused on red blood cell biology, heme biosynthesis, and iron homeostasis. The company operates a ...
Reuters

Disc Medicine eyes standard US approval for drug after FDA denies fast-track nod

Feb 17 (Reuters) - Disc Medicine (IRON.O), opens new tab said on Tuesday it will pursue a traditional U.S. approval pathway for its rare disease drug after the Food and Drug Administration declined to ...
Reuters

US FDA declines to approve Disc Medicine's rare disease drug

Feb 13 (Reuters) - Disc Medicine (IRON.O), opens new tab said on Friday the U.S. Food and Drug Administration declined to approve its drug to treat a rare genetic disorder. The drug, bitopertin, was ...
FierceBiotech

FDA rejects Disc's rare disease drug despite commissioner's voucher

The FDA has rejected a rare blood disease candidate from Disc Medicine, a compound that had been granted expedited review through a newly launched priority voucher program. While the agency agreed ...
STAT

FDA rejects rare disease therapy from Disc Medicine, early recipient of commissioner’s voucher

Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. Adam Feuerstein is a senior ...
CNET

TikTok Ordered to Change Algorithm Over 'Addictive Design,' or Face a Hefty Fine

The EU is threatening to take action against the social media company. It could be the start of a global reckoning. Katie is a UK-based news reporter and features writer. Officially, she is CNET's ...
Psychology Today

Navigating the Impacts of AI-Driven Social Media Algorithms

This article was co-authored with Emma Myer, a student at Washington and Lee University who studies Cognitive/Behavioral Science and Strategic Communication. In today’s digital age, social media has ...